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Structures of an intramembrane vitamin K epoxide
reductase homolog reveal control mechanisms for
electron transfer
Shixuan Liu1,*, Wei Cheng1,*, Ronald Fowle Grider1, Guomin Shen1 & Weikai Li1

The intramembrane vitamin K epoxide reductase (VKOR) supports blood coagulation in
humans and is the target of the anticoagulant warfarin. VKOR and its homologues generate
disulphide bonds in organisms ranging from bacteria to humans. Here, to better understand
the mechanism of VKOR catalysis, we report two crystal structures of a bacterial VKOR
captured in different reaction states. These structures reveal a short helix at the hydrophobic
active site of VKOR that alters between wound and unwound conformations. Motions of this
‘horizontal helix’ promote electron transfer by regulating the positions of two cysteines in an
adjacent loop. Winding of the helix separates these ‘loop cysteines’ to prevent backward
electron ﬂow. Despite these motions, hydrophobicity at the active site is maintained to
facilitate VKOR catalysis. Biochemical experiments suggest that several warfarin-resistant
mutations act by changing the conformation of the horizontal helix. Taken together, these
studies provide a comprehensive understanding of VKOR function.
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H

uman vitamin K epoxide reductase (VKOR) is an integral
membrane protein that supports the activity of vitamin
K-dependent proteins, which are involved in a variety of
physiological processes including blood coagulation, bone
mineralization1, energy metabolism2, calcium homeostasis,
signal transduction, cell growth and apoptosis3,4. VKOR is the
target of warfarin, the most commonly used anticoagulant that
treats and prevents deep vein thrombosis, pulmonary embolism,
stroke and myocardial infarction.
VKOR functions through the vitamin K cycle in the
endoplasmic reticulum (ER). The cycle begins with the gcarboxylation of several glutamic acids in vitamin K-dependent
proteins such as coagulation factors; this post-translational
modiﬁcation is required for their activation at the sites of injury5.
The g-carboxylase activity results in the epoxidation of the
vitamin K hydroquinone. The role of VKOR is to regenerate the
hydroquinone by reducing the vitamin K epoxide, with a vitamin
K quinone serving as an intermediate. Each step of the reduction
results in the formation of a disulphide bond at the active site of
VKOR. To regenerate the reduced active site, VKOR requires
partner proteins that pass the disulphide to newly synthesized
proteins containing free cysteines6,7.
Homologues of VKOR have been found in bacteria, archaea,
plants, insects and mammals8. Bacterial VKOR homologues
constitute a large family of enzymes that generate disulphide
bonds in the periplasmic space, a function similar to that of a
DsbB protein9. Archaeal VKORs promote disulphide-bond
formation in cytoplasmic proteins to improve their stability at
extreme conditions10. In Arabidopsis, a VKOR homologue
likely catalyses disulphide-bond formation in the thylakoid11.
A recent study found that VKOR also contributes to disulphidebond formation in the ER lumen of mammals12. Knockdown
of VKOR expression in combination with other ER-associated
disulphide-bond-forming enzymes results in complete cell
death. Taken together, it becomes increasingly clear that
VKOR is broadly involved in disulphide-bond formation, which
is crucial for the maturation of many secretory proteins by
ensuring their timely folding and by preventing protein
aggregation13.

We previously determined the 3.6-Å crystal structure of a
bacterial VKOR homologue from Synechococcus sp. (ssVKOR)
with its autologous reducing partner, a thioredoxin-like (Trx)
domain14. At the VKOR active site, a CXXC motif (Cys130 and
Cys133) is in close proximity to a quinone molecule. Another pair
of conserved cysteines (Cys50 and Cys56) is located in a loop
region, which is followed by a short helix we termed the
horizontal helix (Fig. 1a). These ‘loop cysteines’ were proven to be
essential in mediating disulphide exchange between the active
sites of ssVKOR and Trx14, which contains another CXXC motif
(Cys209 and Cys212). The disulphide exchange is accompanied
by the sequential transfer of electrons from Trx to the VKOR
domain (Fig. 1a). The electron-transfer intermediates can be
captured by mutating one cysteine in a pair to generate a free
thiol, which can subsequently reduce its target disulphide
(Fig. 1b). Using this strategy, we determined this previous
structure with a Cys56Ala mutation captured in a state where
electrons are being transferred from the Trx domain to the loop
cysteines.
Despite VKOR’s widespread role in assisting oxidative protein
folding and blood coagulation, the physical mechanisms of
electron transfer in VKOR remain unclear. The loop cysteines
(Cys50/Cys56) have to change conformation in order to gain
access to the two active sites of the VKOR and Trx domains,
which are separated by a 16-Å distance. In addition, how VKOR
promotes an electron ﬂow in the forward direction15,16 is
completely unknown. Elucidating these mechanisms requires
structures to be determined of other VKOR electron-transfer
states, especially the state when the electrons are transferred from
the loop cysteines to the active site of VKOR.
Here we report two new structures of ssVKOR captured in
different conformational states to visualize later stages of the
electron-transfer pathway. Comparison of the structural intermediates reveals the importance of the horizontal helix that
undergoes unwinding motions to promote electron transfer. The
N-terminal part of this helix acts like a spring: its unwound state
facilitates the electron transfer from the Trx active site, and its
helical state allows the electron transfer to the VKOR active site.
Winding of the helix also separates the loop cysteines to prevent
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Figure 1 | The electron transfer pathway. The electron transfer process can be followed by the changes of sulfhydryls (coloured in green). (a) State I: at
this initial state, Cys209 and Cys212 at the active site of the Trx domain have been reduced by nascent proteins. The Cys209 and Cys212 sulfhydryls
will subsequently reduce the Cys50-Cys56 disulphide. State II: Cys209/Cys212 forms a mixed disulphide with Cys50/Cys56. The red arrow shows a
possible backward reaction in which the Cys56 attacks the Cys50-Cys209 disulphide. A Cys56Ala mutation (red asterisk) directly prevents this backward
attack (black cross) and stabilizes the Cys50-Cys209 disulphide. State III: physical separation of Cys56 from Cys50-Cys209 disulphide may also
prevent the backward attack. The free Cys56 can interact with Cys130/Cys133 at the active site of VKOR, leaving behind the Cys50/Cys209/Cys212.
A Cys212Ala mutation (red asterisk) can stabilize this state. State IV: the free Cys50 reduces the Cys56-Cys130 disulphide. A Cys50Ala mutation prevents
this attack and stabilizes the Cys56-Cys130 disulphide. (b) The strategy of capturing electron-transfer intermediates. A single mutation (red asterisk)
in a cysteine pair will generate a free thiol in the other cysteine, which subsequently reduces another cysteine pair and forms an alternative disulphide.
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futile electron transfer in the reverse direction. During these
motions, the hydrophobic residues of the horizontal helix remain
covering the quinone-binding pocket and maintain a lowdielectric environment that is likely important for quinone
reduction and disulphide-bond formation in VKOR. Biochemical
experiments support this spring model and reveal that several
warfarin resistance mutations may act by altering the orientation
of the horizontal helix.
Results
Structure determination. We made two constructs that would
likely capture later stages of the electron transfer (Fig. 1a): a
Cys50Ala mutant containing a Cys56 thiol, which may reduce
Cys130-Cys133 at the active site of ssVKOR (state IV), and a
Cys212Ala mutant containing a Cys209 thiol, which may reduce
Cys50-Cys56 in the loop region. If the electron transfer continues,
the reduced Cys56 thiol will subsequently react with the Cys130Cys133 disulphide (state III).
The Cys50Ala crystals diffracted to 2.8 Å (Supplementary
Fig. 1) after dehydration, and the molecular replacement (MR)
solution was found by using individual domains from the
Cys56Ala structure14 as search models. Omit maps with a series
of deletions (see Methods) were used for manual building of the
Cys50Ala model (Fig. 2), which was reﬁned to an Rfree value of
24.5% (Table 1). An omit map, calculated with the deletion of the
loop/helix region connecting TM1 and TM2 from the MR model,
generated electron density indicating a conformational change in
this region (Fig. 3).
The Cys212Ala mutant was crystallized, in a different space
group, using high concentrations of lipid and detergent17. These
Trx domain

Prolinerich
loop

C212
Electron
transfer loop

Overall structures. The Cys50Ala structure (Fig. 2) represents the
state in which electrons are transferred from Cys56 to the VKOR
active site. Compared with the Cys56Ala structure in state II, the
Trx domain has rotated by 20 degrees towards the VKOR
domain. This rigid body rotation is hinged through a proline-rich
region that connects the two domains. Rotation of the Trx
domain is probably induced by a downward ﬂipping of the
electron-transfer loop (containing Cys50/Cys56), which would
otherwise prevent the movement of the Trx domain.
The Cys212Ala structure (Fig. 3a, middle), in state III, has
some characteristics from both the Cys56Ala (state II) and
Cys50Ala (state IV) structures. The electron-transfer loop has its
N-terminal part inserted into the Trx-binding groove and its Cterminal part is close to the VKOR active site. Importantly, Cys50
and Cys56 are now separated by a distance of 410 Å after the
Cys50-Cys56 disulphide is reduced by the free Cys209. This
physical separation may prevent backward electron transfer.
In these different electron-transfer states, the VKOR and Trx
domains retain their architectures, a 4-helix bundle and a
thioredoxin fold, respectively (Fig. 2). However, conformational

Table 1 | Data collection, phasing and reﬁnement statistics*.
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domain
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crystals diffracted only to 4.2 Å. Although the resolution is low, an
omit map showed the regeneration of the entire loop region
(Supplementary Fig. 2) and we were able to roughly build the Ca
trace of this loop (Fig. 3a).
Owing to its higher accuracy, the reﬁned 2.8-Å structure was
used to re-calculate omit maps for the Cys56Ala mutant; these
model maps were very similar to the experimental map previously
obtained14. Thus, the electron density at the horizontal helix
(Fig. 3b) of the Cys56Ala mutant was conﬁrmed by two
independent phasing methods. In sum, three electron-transfer
states have been captured, in which the structures of Cys56Ala,
Cys212Ala and Cys50Ala mutants (Fig. 3a) represent the states II,
III and IV (Fig. 1a), respectively.

TM1

Cytoplasm
Figure 2 | Overall structure of the ssVKOR in state IV. The transmembane helices (TM1–4) homologous to the mammalian VKOR are
coloured in pink, the Trx domain in blue and the electron-transfer loop and
the horizontal helix in red. The dotted lines indicate the membrane
boundary. The quinone and conserved cysteines are labelled.

Data collection
Space group
Cell dimensions
a, b, c (Å)
a, b, g (°)
Resolution (Å)
Rsym or Rmerge
I/sI
Completeness (%)
Redundancy
Reﬁnement
Resolution (Å)
No. of reﬂections
Rwork/Rfree
No. of atoms
Protein
Ligand/ion
Water
B-factors
Protein
Ligand/ion
Water
R.M.S. deviations
Bond lengths (Å)
Bond angles (°)

ssVKOR C50A
before
dehydration

ssVKOR C50A
after
dehydration

ssVKOR
C212A

C2221

C2

P61

130.8, 142.5,
69.0
90, 90, 90
50–3.6
0.067 (0.922)
33.7 (1.6)
98.9 (95.1)
6.9 (6.0)

140.8, 118.8, 139.6, 139.6, 68.7
68.0
90, 89.8, 90
90, 90, 120
50–2.8
50–4.2
0.078 (0.762)
0.111 (0.949)
15.2 (1.7)
16.4 (2.3)
99.8 (100.0)
99.9 (100.0)
3.6 (3.8)
9.5 (9.5)

50–3.6
6,578
27.4/32.2

50–2.8
24,812
23.2/24.5

50–4.2
5,713
29.9/33.1

1,994
32
0

3,931
64
0

1,994
32
0

71.6
122.8
N/A

39.9
66.5
N/A

91.4
86.1
N/A

0.005
1.078

0.005
0.900

0.005
0.842

N/A, not available; R.M.S., root mean square; ssVKOR, vitamin K epoxide reductase homologue
from Synechococcus sp.
*In each case, the data were collected from one crystal.
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Figure 3 | Conformational changes in the loop/helix region between different electron transfer states. (a) Zoomed views of the Cys56Ala (left),
Cys212Ala (middle) and Cys50Ala (right) structures. Conformational changes are observed in the electron-transfer loop and horizontal helix.
(b) Left, electron density map (contoured at 1s) of Cys56Ala horizontal helix. The Cys56Ala structure (gold) is superimposed with Cys50Ala structure
(grey). The difference becomes evident towards the N-terminus of the horizontal helix: from Leu58 to Cys56 (residues of the Cys50Ala construct
labelled in parenthesis). Right, electron density map (contoured at 1s) of Cys50Ala horizontal helix (grey).

changes are observed in the electron-transfer loop and in the
horizontal helix that covers on top of the VKOR active site
(Fig. 3).
Conformational changes in different electron transfer states.
The electron-transfer loop undergoes a large conformational
change between different states. In the Cys56Ala and Cys212Ala
structures (Fig. 3a), the N-terminal part of the loop binds to a
small binding groove of the Trx domain through hydrophobic
interactions and a disulphide bond of Cys50-Cys209. In contrast,
this entire loop in the Cys50Ala structure ﬂips down using Glu44
as a hinge; Glu44 is at the C-terminal end of the TM1 helical
region. Residues Ala47 to Phe49 may have inserted into the
membrane phase, as judged by their positions relative to the TM
region.
Conformational changes in the horizontal helix are clear in the
two structures of higher resolution (Fig. 3b). In the Cys50Ala
structure, the N-terminal end of the horizontal helix becomes
more compact when Cys56 and Cys130 form a disulphide bond.
The horizontal helix adopts a typical a-helical conformation, and
four hydrogen bonds could be formed from Gly55 to Ser62. In
contrast, in the Cys56Ala structure, the horizontal helical region
adopts an unwound conformation; the Ca trace is no longer
a-helical and only two hydrogen bonds are potentially formed.
When these two structures are superimposed at the horizontal
helix region, the C-terminal residues, Ser62 to Trp64, superimposes relatively well; however, the difference becomes obvious
from Leu58 towards N-terminus of the horizontal helix (Fig. 3b,
left). The conformational changes of the horizontal helix in
different states suggest that VKOR uses this helix to promote
electron transfer.
4

Coordination of the horizontal helix and the loop cysteines.
How does the winding and unwinding motions of the horizontal
helix promote electron transfer? Since Cys56 is located at the
exact N-terminal end of this helix, we postulated that the motions
of horizontal helix may drag Cys56 back and forth for electron
transfer. To illustrate this mechanism, we made a series of constructs that inserted residues between Cys56 and the horizontal
helix. The rate of electron transfer was determined by using
reduced and unfolded RNaseA as the electron donor14. The
RNaseA reduces the Trx active site, and the loop cysteines
subsequently transfer the electrons to the VKOR active site. In
contrast, the electron transfer can be bypassed by using
dithiothreitol (DTT) as the reductant, which is membranepermeable and can directly reduce the VKOR active site. Using
this assay, we found that all of the insertion mutations
signiﬁcantly lowered the rate of electron transfer; however, the
rate of vitamin K reduction at the active site was largely
unaffected (Fig. 4). A control experiment using Cys56Ala blocked
the vitamin K reduction promoted by RNaseA, but not by DTT.
The horizontal helix and warfarin-resistant mutations. As the
horizontal helix is important for tethering Cys56 to the membrane, we examined the extent to which the helix is buried inside
the membrane. We used a labelling method developed for DsbD
and DsbB18,19: a residue mutated to cysteine is ﬁrst modiﬁed by a
membrane-impermeable maleimide probe, AMS (4-acetamido40 -maleimidylstilbene-2,20 -disulfonic acid; 0.54 kDa). The protein
is subsequently denatured, and unblocked cysteines are labelled
by a larger maleimide probe, MalPEG 5 kDa. Thus, the relative
extent of modiﬁcation by AMS and MalPEG shows the
membrane accessibility of the mutated residue. Using this
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method, we found AMS was capable of labelling residues
Asp57Cys, Leu58Cys, Ser61Cys and Ser62Cys located on the
aqueous side of the horizontal helix (Fig. 5a). However, the

Relative vitamin K
reduction activity (%)

120%

DTT

C
56

RNaseA

100%
C
G

C
G
A

80%
A

C
A

60%

C
G
G
S
G
S

40%
20%

57
G
G
SG
S

57
G

G
54
C
/C
56
A
G
55
C
/C
56
A

C
56
A

W
T

0%

Figure 4 | Proximity of Cys56 and horizontal helix is required for electron
transfer. Inserting residues between Cys56 and the horizontal helix
lowers the rate of electron transfer, which is initiated by RNaseA reduction
of the Trx domain (red bars). The DTT reduction at the active site (blue
bars) is largely unchanged. Error bars represent s.e. of three duplicated
measurements. Mutants with insertion between Cys56 and the horizontal
helix (orange box) were made by either moving Cys56 (red) to a
different position on the polypeptide chain through mutations (Gly55Cys/
Cys56Ala, Gly54Cys/Cys56Ala) or by inserting a ﬂexible linker (Gly or
Gly-Gly-Ser-Gly-Ser) between Cys56 and Gly57. The mutated residues are
shown in blue and the inserted residues in green.

residues Val59Cys and Leu60Cys located on the membrane side
were not efﬁciently labelled. Therefore, it seems that the
horizontal helix is partially buried in the membrane.
Interestingly, several warfarin-resistant mutations identiﬁed in
human and rodents have been mapped on or close to the
horizontal helix of ssVKOR (Fig. 5b); patients having these
resistant mutations show a signiﬁcantly higher requirement for
warfarin dosage20–22. Do these mutations affect the conformation
of the horizontal helix? Using the method described above, we
found that the Asp57Leu, Val59Leu, Ser61Phe and Arg63Gly in
ssVKOR (corresponding to Ser52Leu, Val54Leu, Ser56Phe and
Arg58Gly in human VKOR) all increased the membrane
accessibility of Leu60Cys on the horizontal helix (Fig. 5c). The
change of AMS modiﬁcation to Leu60Cys can be explained by a
movement of the horizontal helix that weakens its membrane
association (Fig. 5d). In other words, the warfarin-resistant
mutations appear to induce a conformational change in the
horizontal helix region.
VKOR active site. The Cys50Ala structure at 2.8 Å resolution
provides mechanistic insights into the quinone reduction and
disulphide-bond formation at the VKOR active site. We observed
continuous electron density connecting the quinone, VKOR’s
CXXC motif and a loop cysteine (Fig. 6a). The densities show the
disulphide-bonded forms of Cys56-Cys130 and Cys130-Cys133,
and a covalent link between Cys133 and the quinone. The continuous density probably reﬂects an averaging effect because
different molecules in the crystal can have alternative ways of
forming a covalent bond. The orientation of the quinone is well
deﬁned by the density map, and in one alternative state Cys133
may link covalently to the C1 atom of the quinone ring (Fig. 6b).
The C1 atom and the three sulphurs in Cys56, Cys130 and
Cys133 are aligned in a straight line (Fig. 6a), a preferred
orientation for the nucleophilic attack by a thiolate group23. The
Met118 residue stacks at the bottom of the quinone ring and
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Figure 5 | Membrane accessibility of the horizontal helix and effect of warfarin-resistant mutations (WRs). (a) Residues on the horizontal helix
show different accessibilities to AMS, a membrane-impermeable probe. (b) Many WRs (blue circles) are located between TM1 and TM2 in human VKOR.
(c) Corresponding WRs in ssVKOR changing the AMS labelling of Leu60Cys. The mutant proteins are initially labelled by membrane-impermeable
AMS (0.5 kDa). After TCA precipitation, the unblocked cysteine is modiﬁed by MalPEG (5 KDa). Thus, the relative extent of AMS and MalPEG labelling
indicates the membrane accessibility of Leu60Cys. (d) These WRs may induce a movement of the ﬂexible horizontal helix, which may cause
resistance by altering the putative warfarin-binding pocket.
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ssVKOR mutants. Shifted pH optima are observed for Val59 and Leu60 mutant proteins, which are hydrophobic residues surrounding Cys133. However, this
effect is not seen for mutations of nearby residues, Asp57 and Leu58.

assists to position the quinone to react with Cys133 (Fig. 6c).
Ser62, a residue conserved among all VKORs, is close to the
quinone ring. Interestingly, Cys133 is buried in a hydrophobic
pocket, which is formed by Val59 and Leu60 from the horizontal
helix and Leu37, Met122 and Tyr132 from the transmembrane
helices (Fig. 6c).
VKOR activity and the hydrophobic pocket. Since another
disulphide-forming enzyme, DsbB, uses an essential arginine to
assist catalysis by stabilizing the transition state (Supplementary
Fig. 4c), we ﬁrst investigated the role of basic residues in ssVKOR.
Lys41 is not conserved among VKORs but is the only basic
residue close (B4.5 Å) to the quinone (Fig. 6c). We found that
the Lys41 mutants (Ser/Ala/Glu) of ssVKOR did not result in loss
of much activity (Supplementary Fig. 3).
If a basic residue is not absolutely required, could the
hydrophobic pocket in ssVKOR play a role in catalysis by
activating the Cys133 thiol? Despite the conformational changes
6

in different structures (Fig. 3a), the catalytic residue Cys133
(which interacts with the quinone) remains in the hydrophobic
pocket. To test the importance of this hydrophobic environment,
we exposed the Cys133 to water by shortening the side chains of
residues (for example, mutate Leu60 to Ala) on the horizontal
helix, which forms part of the hydrophobic pocket. Interestingly,
not only did these mutants show a signiﬁcant loss of activity, but
the pH optimum of ssVKOR activity was also shifted from 7.5 to
8.5 (Fig. 6d). However, mutating the nearby residues, Asp57 and
Leu58, which are not part of the hydrophobic pocket, did not
have the same effect on the enzymatic activity.
Discussion
The Cys50Ala structure of ssVKOR at 2.8 Å resolution allowed a
detailed analysis of an intramembrane enzyme that generates
disulphide bonds. In the active site, a continuous electron density
connects the thiol group of Cys133 with the C1 atom of the
quinone ring (Fig. 6a), clearly demonstrating the proposed
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chemistry of the disulphide bond generation in VKOR24,25 or
DsbB26. In these models, a deprotonated thiolate serves as a
nucleophile to attack the C1 group of the quinone, and
rearrangement of the covalent bonds generates a disulphide
(Fig. 6b).
Compared with DsbB, ssVKOR probably uses a different
mechanism to activate this catalytic thiol. DsbB has a hydrophilic
pocket and uses an essential arginine to neutralize the negative
charge of a deprotonated thiolate (Supplementary Fig. 4c),
thereby stabilizing the transition state of the reaction27. In the
ssVKOR structure, Lys41 is the only basic residue that is close to
the active site but is not essential for activity (Supplementary
Fig. 3). Since thiol deprotonation correlates with its pKa, which
is known to be very sensitive to the local environment28,29, the
hydrophobic pocket in ssVKOR (Fig. 6c) may play a role in
lowering the pKa of Cys133 for its deprotonation at neutral pH.
A lowered thiol pKa in a hydrophobic environment has been
suggested on the basis of theoretical calculations of thiol
reactions30 and has been observed in other membrane
proteins31. When hydrophobic residues Val59 and Leu60
covering the active site are mutated and Cys133 is exposed to
water, ssVKOR exhibits much lower enzymatic activity (Fig. 6d).
The pH optimum in these mutants is shifted back to
about 8.5, possibly reﬂecting a change in the thiol pKa,
which is typically 8.7 in water but can be dramatically lowered
in the microenvironment of a protein32. The hydrophobicity
surrounding the catalytic cysteine is well conserved among VKOR
homologues, suggesting a general mechanism to promote efﬁcient
catalysis in all VKORs. Deprotonation of this cysteine is the ﬁrst
step in VKOR catalysis of quinone reduction and disulphidebond generation. Once the Cys133 thiolate is formed, the
subsequent reactions become kinetically feasible, as predicted
by quantum mechanics calculations of human VKOR33.
The new structures provide an answer to the physical
mechanism of electron transfer in ssVKOR, in which the loop
cysteines (Cys50/Cys56) need to move back and forth to reach the
two active sites that are 16 Å apart (Fig. 2). How this physical
motion can be achieved has been intriguing: Cys56 is attached to
exact N-terminal end of the horizontal helix, which forms part of
the VKOR active site and is unlikely to move away with Cys56.
This apparent mystery can be explained now: the N-terminal part
of the horizontal helix can be unwound, which gives Cys56 the
ﬂexibility to alternatively interact with Cys50 or Cys130 (Fig. 3a).
Inserting a few residues between Cys56 and the horizontal helix
signiﬁcantly lowers the efﬁciency of electron transfer but has little
effect on the vitamin K reduction directly at the active site
(Fig. 4). In these insertion constructs, it is harder for Cys56 to
reach the wound conformation, explaining why the electron
transfer is hindered. From these data, we propose a model in
which the horizontal helix acts as spring to facilitate electron
transfer by undergoing winding and unwinding motions during
the redox cycle. These different conformations may be achieved
by thermal motions, although the wound conformation is
probably more energetically favourable because residues in the
horizontal helix form more hydrogen bonds and have more
interactions with the membrane at this state. Compared with
other disulphide-bond-forming enzymes13,34, motion of a
horizontal helix is a unique feature observed in the VKOR
enzyme.
Electron transfer in VKOR or DsbB needs to ensure the
accessibility of the loop cysteines to their active site buried in a
hydrophobic membrane environment. Probably as a result of
convergent evolution, both VKOR and DsbB employ a horizontal
helix to tether loop cysteines close to the membrane. Compared
with DsbB19,35, the horizontal helix in VKOR is shorter, less
buried in the membrane and contains fewer hydrophobic residues

(Supplementary Fig. 4a,b). In addition, the horizontal helix in
DsbB is distant from its active site, whereas in VKOR the
horizontal helix forms part of the quinone-binding pocket. The
horizontal helix is an immobile anchor in DsbB; however, it is a
strikingly dynamic component of VKOR that participates in the
process of electron transfer. The unwinding motion of the
horizontal helix in VKOR keeps the hydrophobic residues facing
the active site and thus only causes a slight disturbance to the
local hydrophobic environment. The hydrophobic pocket is thus
sealed from solvent access; this is an important mechanism
to improve the reactivity of the catalytic cysteine. In human
VKOR, the hydrophobic pocket may have the additional
function of protecting the highly reactive vitamin K epoxide
and hydroquinone.
The directionality of the electron transfer in ssVKOR may be
partly controlled by the physical separation of Cys50 and Cys56,
which are 410 Å apart in the Cys212Ala structure. The Cys50Cys56 disulphide does not break until it is reduced by the Cys209
in the Trx domain (Fig. 1a). The reduction generates a free Cys56
that can be separated from Cys50, which is left behind to form a
disulphide with Cys209 (state II). The membrane-association
tendency of the horizontal helix probably can drag the Cys56
away from Cys50. This physical separation seems to be an
effective way to prevent the backward reaction in which the
reduced Cys56 attacks the Cys50-Cys209 disulphide (red arrow in
state II).
The Cys212Ala structure suggests that the transfer of electrons
to the VKOR active site is a one-electron process (Fig. 6b). There
are two possible outcomes after the free Cys209 reduces the
Cys50-Cys56 disulphide: either the reduced Cys56 stays with
Cys209-Cys50 until Cys50 is also reduced, or an electron is
immediately passed on so that the Cys56 forms a disulphide with
Cys130 (Supplementary Fig. 5). The latter state is what has been
observed in the Cys212Ala structure, implying that a more stable
conformation is to have Cys50 and Cys56 separated. Therefore,
electron transfer in ssVKOR may take the following steps:
initially, the Cys50-Cys56 disulphide is reduced, generating an
intermediate with Cys212 and Cys56 taking the sulfhydryls. The
reduced Cys56 is immediately dragged away by the horizontal
helix, leaving behind the Cys209-Cys50 disulphide. Next, the free
Cys56 interacts with Cys130-Cys133 at the VKOR active site.
Importantly, only one electron is transferred during this process,
likely resulting in a semi-reduced quinone. To achieve full
reduction, the second electron has to be passed on, which starts
with the reduction of the Cys209-Cys50 disulphide by the free
Cys212. The reduced Cys50 is now free to attack the Cys56Cys130 disulphide. Therefore, instead of being fully reduced, the
loop cysteines transfer one electron at a time through the
formation of different disulphides.
Functional importance of the ﬂexible horizontal helix suggests
a novel explanation for warfarin resistance. Several warfarinresistant mutations (Asp36Tyr, Val45Ala, Ser52Trp/Leu, Val54Leu, Ser56Phe, Arg58Gly, Trp59Leu/Arg/Cys, Val66Met/Gly,
Gly71/Ala and Asn77Tyr/Ser) identiﬁed in human and rodent
VKORs20–22 are distributed between TM1 and TM2 (Fig. 5b).
How these mutations affect VKOR activity has been unclear
because they do not map to the active site that likely binds
warfarin20–22. We found that several of the corresponding
warfarin-resistant mutations in ssVKOR alter the membrane
accessibility of a buried residue in the horizontal helix (Fig. 5c).
As the horizontal helix is located at the membrane surface, a
conformational change or movement of the helix can be detected
by the change in the membrane accessibility of the buried residue.
Since the horizontal helix forms part of the active site, this
conformational change may weaken warfarin binding. Therefore,
there seems to be two distinct mechanisms causing warfarin
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resistance: mutations around the active site (for example,
Tyr139Phe) in human VKOR may directly prohibit warfarin
binding, and mutations between TM1 and TM2 (for example,
Arg58Gly) may induce a conformational change of the horizontal
helix region. Movement of this helix alters the putative warfarinbinding pocket, resulting in warfarin resistance.
In summary, the VKOR-catalysed disulphide formation and
exchange uses very different mechanisms compared with DsbB.
Unlike DsbB, motions of the horizontal helix in VKOR promote
and control electron transfer while maintaining the hydrophobic
active site important for catalysis. Mutations nearby this ﬂexible
horizontal helix may alter the putative binding pocket of warfarin,
suggesting an explanation for warfarin resistance. In future
studies, it will be interesting to see whether the human VKOR
uses the similar mechanisms.
Methods
Protein puriﬁcation and crystallization. The Cys50Ala and Cys212Ala mutants
of the VKOR homologue from Synechococcus sp. were both expressed in a
BL21(DE3) Escherichia coli strain. The membrane fraction was solubilized in 1%
dodecyl-b-D-maltopyranoside (DDM), 20 mM Tris/HCl pH 7.5, 0.3 M NaCl and
10% glycerol. The detergent soluble fraction was incubated with Ni-afﬁnity resin
and eluted in a buffer containing 20 mM Tris/HCl pH 7.5, 0.1 M NaCl, 0.04%
DDM and 0.3 M imidazole. The subsequent gel ﬁltration chromatography was in
the same buffer without imidazole and the two mutant proteins were concentrated
to about 20 mg ml  1.
The Cys50Ala protein was crystallized in 12% PEG3350, 0.1 M sodium
cacodylate, pH 5.5. The crystals were grown at 22 °C using a sitting-drop vapourdiffusion method and 25% glycerol was initially used as the cryoprotectant for
freezing in liquid nitrogen.
We systematically tested the dehydration of these crystals using small
molecular-weight PEGs. This was based on our observation that using PEG400 as a
cryoprotectant changed the unit cell dimensions of the crystals. After extensive
trials, we found that the best result was achieved by a slow dehydration, in which
PEG300 was added in 5% steps every 12 h to a ﬁnal concentration of 40%. The
crystals were directly frozen in liquid nitrogen after the PEG300 dehydration. With
the use of this protocol, the crystal diffraction improved from 3.6 to 2.8 Å.
The Cys212Ala mutant was crystallized in high concentrations of lipid and
detergent17. A 20-mg ml  1 protein solution was mixed overnight with
15 mg ml  1 1,2-dioleoyl-sn-glycero-3-phosphocholine and 0.5% DDM. This
mixture was crystallized at 22 °C in hanging drop with a buffer containing 11%
PEG1500, 8% glycerol, 5% ethanol, 0.1 M MgCl2, 0.1 M NaCl and 0.1 M sodium
cacodylate, pH 5.5. The crystals were ﬂash-frozen in liquid nitrogen.
Structure determination. The Cys50Ala crystals initially diffracted to 3.6 Å in a
C2221 space group (Supplementary Fig. 1a). Molecular replacement solutions were
obtained by the Phaser program36, which searched for the VKOR domain (residues
1–173) and Trx domain (residues 188–283) from the Cys56Ala structure model14.
The C2221 crystals contained one molecule of the VKOR-Trx in the asymmetric
unit. Omit maps were subsequently calculated using Refmac37 by rigid body
reﬁnement of partial models, in which transmembrane helices and loops were
systematically deleted. The omit maps were sharpened by a B factor of  80 Å2,
and solvent ﬂattening of the maps was calculated by the Parrot program38. An omit
map with the deletion of residues 43–73 regenerated electron densities that
suggested a different conformation of the loop/helix region connecting TM1 and
TM2. The structural model was built manually in Coot39 and reﬁned by the
Refmac program using data corrected for anisotropy.
Dehydration of the crystals improved the diffraction to 2.8 Å (Supplementary
Fig. 1a) and changed the space group to C2 (Supplementary Fig. 1b). One of the
unit cell dimensions shrunk from 131 to 119 Å. Molecular replacement found two
molecules in the asymmetric unit, which resulted from the breakdown of a twofold
crystal symmetry in the C2221 crystals (Supplementary Fig. 1b). A series of omit
maps with deletions mentioned above were calculated, and an initial model was
built from these maps. The maps calculated from the C2 data were very similar to
that from the C2221 data, except that side chain densities were better deﬁned in the
2.8-Å map (Fig. 3b) and residues 49–53 in the electron-transfer loop could not be
built from this map. However, restrained reﬁnement of these models resulted in R
factors 440%. Reﬁnement using a Detwin process installed in Refmac signiﬁcantly
lowered the R factors, and the twinning fraction was reﬁned to 36%. The detwinned
data were sharpened by a B factor of  30 Å2, and the omit maps were averaged
using the twofold noncrystallographic symmetry by the Parrot program. The
averaged omit maps were used to build a 2.8-Å model, which was reﬁned against
the detwinned data to R and Rfree of 23.2% and 24.5%, respectively. At this stage,
composite omit maps were calculated using a torsion-angle-simulated annealing
method installed in the CNS program suite40. The reﬁned model ﬁts well with the
composite omit maps.
8

The crystals of Cys212Ala mutant diffracted to 4.2 Å in a P61 space group. The
VKOR and Trx domains from the 2.8-Å Cys50Ala model were used for MR and for
generating omit maps. The omit maps were improved by solvent ﬂattening (80%
solvent content) using the Parrot program. Electron density for the entire loop/
helix region was regenerated (Supplementary Fig. 2), which had been deleted in the
model.
Owing to its higher accuracy, the 2.8-Å model was also used to re-calculate
model maps for the 3.6-Å Cys56Ala data. We ﬁrst conﬁrmed the conformation of
the loop/helix region by Fo-Fc and 2Fo-Fc maps, which were generated after rigid
body reﬁnement by Refmac. The Fo-Fc map contoured at 3 sigma shows the
positive densities of the electron-transfer loop in its real conformation and negative
densities of the wrong positions in the MR model. We also calculated omit maps by
deleting the region (residues 44–77) of the electron-transfer loop and horizontal
helix. After solvent-ﬂattening, the omit maps (Supplementary Fig. 6) were very
similar to maps obtained previously by experimental phasing methods using a
3.6-Å data set of a mercury derivative14. Thus, these independent phasing methods
generated very similar maps, conﬁrming the conformation changes of the
horizontal helix and the electron-transfer loop.
Activity assay. Reduction of vitamin K was measured using a ﬂuorometric assay14
with the following modiﬁcations. The VKOR protein was ﬁrst incubated with
5 mM DTT (or 0.05 mM of reduced and unfolded RNaseA) to completely reduce
the endogenous quinone, and 0.2 mM vitamin K was subsequently added to initiate
the reaction. To avoid ﬁltering effect from the protein, the excitation and emission
wavelength were changed to 330 nm and 430 nm, respectively.
Probing of membrane accessibility. Membrane accessibility of residues on the
horizontal helix (Supplementary Fig. 7) was detected by an established protocol18,19. The warfarin-resistant mutation was generated on a truncated ssVKOR
construct (residues 1–182) with multiple mutations of Leu60Cys, Cys50Ala,
Cys56Ala, Cys130Ala and Cys133Ala. In other words, only the VKOR domain
is used and all endogenous cysteines have been mutated to alanine. Cells
overexpressing the mutant proteins were lysed by lysozyme to generate
sphereoplast. A membrane-impermeable probe, AMS, was used to label exposed
cysteines. Subsequently, the proteins were denatured by TCA precipitation, and
MalPEG (5 KDa) was used to label unblocked cysteines from the previous step.
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